Annual Current Assets
$270.77 M
+$5.80 M+2.19%
31 December 2023
Summary:
Cogent Biosciences annual total current assets is currently $270.77 million, with the most recent change of +$5.80 million (+2.19%) on 31 December 2023. During the last 3 years, it has risen by +$48.14 million (+21.62%). COGT annual current assets is now at all-time high.COGT Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$341.53 M
-$28.44 M-7.69%
30 September 2024
Summary:
Cogent Biosciences quarterly total current assets is currently $341.53 million, with the most recent change of -$28.44 million (-7.69%) on 30 September 2024. Over the past year, it has increased by +$70.76 million (+26.13%). COGT quarterly current assets is now -22.71% below its all-time high of $441.90 million, reached on 31 March 2024.COGT Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
COGT Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +26.1% |
| 3 y3 years | +21.6% | +53.4% |
| 5 y5 years | +567.1% | +741.4% |
COGT Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +21.6% | -22.7% | +75.4% |
| 5 y | 5 years | at high | +567.1% | -22.7% | +1326.1% |
| alltime | all time | at high | +567.1% | -22.7% | +1326.1% |
Cogent Biosciences Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $341.53 M(-7.7%) |
| June 2024 | - | $369.97 M(-16.3%) |
| Mar 2024 | - | $441.90 M(+63.2%) |
| Dec 2023 | $42.67 M(+19.0%) | $270.77 M(-5.3%) |
| Sept 2023 | - | $285.95 M(-14.5%) |
| June 2023 | - | $334.52 M(+47.8%) |
| Mar 2023 | - | $226.27 M(-14.6%) |
| Dec 2022 | $35.84 M(+278.9%) | $264.97 M(-10.6%) |
| Sept 2022 | - | $296.42 M(-10.4%) |
| June 2022 | - | $330.68 M(+69.8%) |
| Mar 2022 | - | $194.73 M(-12.5%) |
| Dec 2021 | $9.46 M | $222.63 M(+7.3%) |
| Sept 2021 | - | $207.50 M(-6.3%) |
| June 2021 | - | $221.35 M(-4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $232.07 M(-5.2%) |
| Dec 2020 | $6.00 M(-32.0%) | $244.91 M(+83.6%) |
| Sept 2020 | - | $133.42 M(+457.1%) |
| June 2020 | - | $23.95 M(-23.2%) |
| Mar 2020 | - | $31.18 M(-23.2%) |
| Dec 2019 | $8.83 M(+79.3%) | $40.59 M(-15.4%) |
| Sept 2019 | - | $47.98 M(-18.1%) |
| June 2019 | - | $58.60 M(-27.7%) |
| Dec 2018 | $4.92 M(-26.9%) | $81.00 M(-9.5%) |
| Sept 2018 | - | $89.50 M(-7.8%) |
| June 2018 | - | $97.11 M(+175.7%) |
| Mar 2018 | - | $35.23 M(-16.9%) |
| Dec 2017 | $6.74 M(+15.8%) | $42.38 M |
| Dec 2016 | $5.82 M | - |
FAQ
- What is Cogent Biosciences annual total current assets?
- What is the all time high annual current assets for Cogent Biosciences?
- What is Cogent Biosciences quarterly total current assets?
- What is the all time high quarterly current assets for Cogent Biosciences?
- What is Cogent Biosciences quarterly current assets year-on-year change?
What is Cogent Biosciences annual total current assets?
The current annual current assets of COGT is $270.77 M
What is the all time high annual current assets for Cogent Biosciences?
Cogent Biosciences all-time high annual total current assets is $270.77 M
What is Cogent Biosciences quarterly total current assets?
The current quarterly current assets of COGT is $341.53 M
What is the all time high quarterly current assets for Cogent Biosciences?
Cogent Biosciences all-time high quarterly total current assets is $441.90 M
What is Cogent Biosciences quarterly current assets year-on-year change?
Over the past year, COGT quarterly total current assets has changed by +$70.76 M (+26.13%)